FDA identifies four trends in IRB violations from FDA-483s issued in FY 2023.
FDA grants de novo authorization to LumiTheras Valeda light delivery treatment for dry age-related macular degeneration.
FDA approves Caris Life Sciences MI Cancer Seek and its use as a companion diagnostic to identify cancer patients for treatment with several targeted ...
The American Clinical Laboratory Association submits comments to an FDA draft guidance on medical device predetermined change control plans.
In an interview the day after the election, president-elect Donald Trumps top health advisor Robert F. Kennedy Jr. says there are some FDA departments...
FDA grants a fourth breakthrough device designation for SeaStar Medicals Selective Cytopheretic Device.
FDA releases the form FDA-483 with nine observations from an inspection at the Staska Pharmaceuticals outsourcing facility in Bennet, NE.
Three mental health stakeholders call on two FDA advisory committees to recommend changes to the clozapine REMS.